Trials / Unknown
UnknownNCT02934685
IG-VMAT for Localized Prostate Cancer
A Phase III Randomized Study of Hypofractionated Image-guided Volumetric Modulated Arc Radiotherapy (IG-VMAT) Versus Conventionally Fractionated IG-VMAT in Patients With Localized Prostate Cancer
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Beijing Hospital · Other Government
- Sex
- Male
- Age
- 50 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
To determine if hypofractionated IG-VMAT (70 Gy in 28 fractions over 5.6 weeks) will result in disease-free survival (DFS) that is no worse than DFS following conventionally fractionated IG-VMAT (80Gy in 40 fractions over 8 weeks) in patients treated for localized prostate cancer. Analysis the local progression, disease-specific survival (DFS), freedom from biochemical recurrence (FFBR), and overall survival (OS) of two groups. Observe the incidence of GI and GU toxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | hypofraction | 70 Gy in 28 fractions over 5.6 weeks |
| RADIATION | convention | 80Gy in 40 fractions over 8 weeks |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-02-01
- Completion
- 2021-05-01
- First posted
- 2016-10-17
- Last updated
- 2016-11-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02934685. Inclusion in this directory is not an endorsement.